Schlussman Stefan D, Zhou Yan, Bailey Alexis, Ho Ann, Kreek Mary Jeanne
The Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY 10021, USA.
Brain Res Bull. 2005 Oct 15;67(3):169-75. doi: 10.1016/j.brainresbull.2005.04.018.
This study examined the effects of chronic (14-day) steady-dose and escalating-dose "binge" pattern cocaine administration on striatal preprodynorphin (ppDyn) mRNA levels and behavioral stereotypies. Animals in the steady-state and escalating groups received cocaine in a "binge" pattern (three equal injections starting 30 min following the start of the daily light cycle, separated by 1 h). The dose of cocaine in the "steady-dose" group was 15 mg/kg/injection and remained constant throughout the study. The escalating group received 15 mg/kg/injection on days 1-3, 20 mg/kg/injection on days 4-6, 25 mg/kg/injection on days 7-9 and 30 mg/kg/injection thereafter, for a maximum daily dose of 90 mg/kg. Levels of ppDyn mRNA were determined by solution hybridization. Cocaine significantly affected body weight. Both steady-dose and escalating-dose "binge" cocaine administration resulted in expression of behavioral stereotypy and induced intense, rapid head movements which were dose- and time-dependent. Cocaine, independent of dose, increased ppDyn mRNA levels in the caudate putamen (CPu), but not in the nucleus accumbens (NAc). These data suggest that the ppDyn response to cocaine in the CPu is not dose-dependent or that it has reached a maximal level at the 45 mg/kg daily dose.
本研究考察了慢性(14天)稳定剂量和递增剂量“ binge”模式可卡因给药对纹状体前强啡肽原(ppDyn)mRNA水平和行为刻板症的影响。稳态组和递增组的动物以“ binge”模式接受可卡因(在每日光照周期开始后30分钟开始进行三次等量注射,间隔1小时)。“稳定剂量”组的可卡因剂量为15mg / kg /注射,并且在整个研究过程中保持恒定。递增组在第1-3天接受15mg / kg /注射,在第4-6天接受20mg / kg /注射,在第7-9天接受25mg / kg /注射,此后接受30mg / kg /注射,最大日剂量为90mg / kg。通过溶液杂交测定ppDyn mRNA水平。可卡因显著影响体重。稳定剂量和递增剂量“ binge”模式的可卡因给药均导致行为刻板症的表现,并引发强烈、快速的头部运动,这些运动具有剂量和时间依赖性。可卡因,无论剂量如何,均可增加尾壳核(CPu)中的ppDyn mRNA水平,但不增加伏隔核(NAc)中的ppDyn mRNA水平。这些数据表明,CPu中ppDyn对可卡因的反应不是剂量依赖性的,或者在每日45mg / kg的剂量下已达到最大水平